0 Yorumlar
0 hisse senetleri
2K Views
0 önizleme
Site içinde arama yapın
Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek
-
Please log in to like, share and comment!
-
Global Doripenem Market to Reach USD 680 Million by 2034 Amid Rising Antibiotic Resistance and Hospital-Acquired InfectionsAccording to a new report from Intel Market Research, the global Doripenem market was valued at USD 450 million in 2024 and is projected to reach USD 680 million by 2034, growing at a steady CAGR of 4.1% during the forecast period (2025–2034). This growth stems from escalating antibiotic resistance and increasing prevalence of hospital-acquired infections requiring last-resort...0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme
-
Global Neomycin Market Set to Reach USD 620 Million by 2034 Amid Rising Infection BurdenAccording to a new report from Intel Market Research, the global Neomycin market was valued at USD 420 million in 2025 and is projected to reach USD 620 million by 2034, growing at a steady CAGR of 4.1% during the forecast period (2026–2034). This growth is fueled by rising antibiotic demand in human healthcare and veterinary medicine, coupled with increasing prevalence of bacterial...0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme
-
Systemic Infection Treatment Market to Reach USD 22.1 Billion by 2031 | CAGR 6.4%According to a newly published market research report by 24LifeSciences, global systemic infection treatment market was valued at USD 14.3 billion in 2024 and is projected to reach USD 22.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.4% during the forecast period 2025-2031. Systemic infection treatments combat infections that have spread throughout the bloodstream...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme
-
Systemic Infection Treatment Market to Reach USD 22.1 Billion by 2031 | CAGR 6.4%According to a newly published market research report by 24LifeSciences, global systemic infection treatment market was valued at USD 14.3 billion in 2024 and is projected to reach USD 22.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.4% during the forecast period 2025-2031. Systemic infection treatments combat infections that have spread throughout the bloodstream...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme